Options Show Bullish Tilt on Forest Labs

Hefty demand for options that would benefit if shares of the drug developer extend a rally suggests that some investors think it could be bought out.



via WSJ.com: Markets http://online.wsj.com/article/SB10001424052702304753504579284622336162960.html?mod=rss_markets_main